Dilution from the Exercise of Stock Acquisition Rights
First written in FY2022. 9 of 13 entries say "Materialised", first in FY2023-Q2. Latest entry: 2026-10-22.
The whole theme swung hardest in 2017: 37 of 68 companies on the "Worse" side.
- 2026-10-22RestatedM&A and Subsidiary Changes
「The breakdown of the stock acquisition rights outstanding as of 30 June 2026 is as follows. At a meeting of our Board of Directors held today, we also resolved, conditional on the successful completion of the tender offer, to give comprehensive approval for holders of these stock acquisition rights to transfer them to the Tender Offeror by tendering them in the tender offer, limited to stock acquisition rights that were actually tendered.」
The disclosure showed 120,900 stock acquisition rights outstanding, representing 60,450 underlying shares, and explained the approval of transfers associated with tendering them in the tender offer. - FY2026SoftenedAnnual report
「The Company has granted stock acquisition rights in the form of stock options to provide incentives to its officers, employees and external collaborators. As of 31 March 2026, potential shares represented 0.98% of total shares issued.」
The potential share ratio declined from 3.97% in the previous fiscal year to 0.98%. Meanwhile, during the fiscal year, the number of shares increased by 10,200 through the exercise of stock acquisition rights and by 23,331 through the delivery of share-based compensation. - 2026-05-14MaterialisedEarnings
「Proceeds from the issuance of shares through the exercise of stock acquisition rights during the fiscal year 3,284」
The company again received proceeds from issuing shares through the exercise of stock acquisition rights during the fiscal year, and the number of shares issued and outstanding at fiscal year-end was 4,377,916. - FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 9,050 4,366,536 1,457 417,948 1,457 441,948 (Note) 3. Increase due to the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 9,050 during the interim consolidated accounting period. Total shares issued at the end of the interim period stood at 4,366,536, and 4,377,566 as of the filing date. - FY2025-H1MaterialisedAnnual report
「Cash flows from financing activities during the interim consolidated accounting period resulted in an inflow of ¥32.662 million. This was mainly due to proceeds of ¥48.232 million from the issuance of bonds with stock acquisition rights and proceeds of ¥18.160 million from the issuance of shares upon exercise of stock acquisition rights, partly offset by ¥32.970 million in repayments of long-term borrowings.」
During the interim consolidated accounting period, the Company received ¥18.160 million from the issuance of shares upon exercise of stock acquisition rights. Total shares issued increased by 57,650 during the period, reaching 4,340,451 as of the filing date. - FY2024SoftenedAnnual report
「The Company has granted stock acquisition rights in the form of stock options to provide incentives to its officers, employees and external collaborators. As of 31 March 2024, potential shares represented 3.97% of total shares issued.」
The potential share ratio declined from 5.45% in the previous fiscal year to 3.97%. Meanwhile, the number of shares increased by 47,950 during the fiscal year through the exercise of stock acquisition rights. - FY2024-Q3MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
Between October and December 2023, the number of shares increased by 5,700 through the exercise of stock acquisition rights, and capital stock and capital reserves each increased by ¥917 thousand. As of the filing date, total shares issued stood at 4,274,200. - FY2024-Q2MaterialisedAnnual report
「Cash flows from financing activities during the cumulative second-quarter period resulted in an outflow of ¥10.315 million, compared with an inflow of ¥517.528 million in the same period of the previous year. This was due to proceeds of ¥13.234 million from the issuance of shares upon exercise of stock acquisition rights, offset by ¥23.550 million in repayments of long-term borrowings.」
During the cumulative second-quarter period, the Company received ¥13.234 million from the issuance of shares upon exercise of stock acquisition rights, and the number of shares increased by 2,500 between 1 July and 30 September. An additional 5,000 shares were issued by the filing date, indicating that events underlying the dilution risk continued to occur. - FY2024-Q1MaterialisedAnnual report
「The increase resulted from the exercise of share acquisition rights.」
The exercise of stock acquisition rights increased the number of shares by 38,600 during the first quarter, and increased capital stock and capital surplus by ¥6.214 million each. Additional new shares were issued, providing a further realization of an event underlying the dilution risk. - FY2023MaterialisedAnnual report
「The Company has granted stock acquisition rights in the form of stock options to provide incentives to its officers, employees and external collaborators. As of 31 March 2023, potential shares represented 5.45% of total shares issued.」
The Company disclosed a potential share ratio of 5.45%, while 13,750 shares were added during the fiscal year through the exercise of stock acquisition rights. - FY2023-Q3MaterialisedAnnual report
「In addition, during the cumulative third-quarter period, the Company issued new shares upon the exercise of a portion of the first series of stock acquisition rights, increasing capital stock and capital surplus by ¥2.133 million each.」
A portion of the stock acquisition rights was exercised and new shares were issued during the cumulative third-quarter period as well, providing an additional realization of an event underlying the dilution risk. - FY2023-Q2MaterialisedAnnual report
「In addition, during the cumulative second-quarter period, the Company issued new shares upon the exercise of a portion of the first series of stock acquisition rights, increasing capital stock and capital surplus by ¥1.392 million each.」
A portion of the stock acquisition rights was actually exercised and new shares were issued. Total shares issued stood at 4,221,150 at the end of the quarter, and an event underlying the dilution risk from potential shares has occurred in part. - FY2022First statedAnnual report
「As of 31 March 2022, potential shares represented 8.18% of total shares issued. If these stock acquisition rights are exercised, the value of shares held by existing shareholders and their voting rights percentages may be diluted.」
The Company discloses the percentage of potential shares represented by stock options granted to officers, employees and external collaborators.